Clinical trial
PROspective Multicentre Study to Identify Diagnostic Key PERfOrmance Indicators in Upper GI Endoscopy (PROSPERO)
NCT04843397 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROspective Multicentre Study to Identify Diagnostic Key PERfOrmance Indicators in Upper GI Endoscopy (PROSPERO)
- Lead sponsor
- University of Cambridge
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2021
- Completion date
- September 15, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
barrett esophagus, barretts esophagus with dysplasia, duodenal adenoma, duodenum cancer, esophageal cancer, esophageal dysplasia, gastric atrophy, gastric cancer, gastric intestinal metaplasia, gastric polyp